We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Credit Suisse (CS), Nomura (NMR) to be Hit by Archegos' Default
Read MoreHide Full Article
Credit Suisse and Nomura Holdings (NMR - Free Report) are expecting to take a major hit in first-quarter 2021 results, as a U.S.-based hedge fund, supposedly linked to Archegos Capital Management, defaulted on margin calls made last week by the banks.
A margin call requires a client to add funds to its account if the value of an asset declines below a specified level. Archegos failed to respond to the call, which led investment banks providing service to the hedge fund to dump large quantities of ViacomCBS and Chinese tech cos, in which it held positions.
In a trading update provided recently, Credit Suisse said that though it might be early to measure the exact size of the loss resulting from its plans to exit, it expects the amount to be highly significant and material to the first-quarter results.
Similarly, on Monday, Nomura said that it estimates the amount of the claim to be nearly $2 billion based on market prices as of Mar 26. However, the figure may change depending on unwinding of the transactions and fluctuations in market prices.
Some of the other banks that were affected by this default are Deutsche Bank (DB - Free Report) and UBS Group (UBS - Free Report) . Deutsche Bank's exposure to the fund was very limited in comparison to others. Per a Bloomberg article, the bank did not incur any losses and is in the process of managing its position.
Also, Goldman Sachs expects any loss it may face from Archegos to be immaterial, as its loans to Archegos were fully collateralized. Per the article, Goldman is among the first banks to reduce its exposure and has exited most of its Archegos-related positions.
Shares of Credit Suisse and Nomura have gained 14.3% and 24%, respectively, over the past six months compared with 49.1% growth of the industry.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Credit Suisse (CS), Nomura (NMR) to be Hit by Archegos' Default
Credit Suisse and Nomura Holdings (NMR - Free Report) are expecting to take a major hit in first-quarter 2021 results, as a U.S.-based hedge fund, supposedly linked to Archegos Capital Management, defaulted on margin calls made last week by the banks.
A margin call requires a client to add funds to its account if the value of an asset declines below a specified level. Archegos failed to respond to the call, which led investment banks providing service to the hedge fund to dump large quantities of ViacomCBS and Chinese tech cos, in which it held positions.
In a trading update provided recently, Credit Suisse said that though it might be early to measure the exact size of the loss resulting from its plans to exit, it expects the amount to be highly significant and material to the first-quarter results.
Similarly, on Monday, Nomura said that it estimates the amount of the claim to be nearly $2 billion based on market prices as of Mar 26. However, the figure may change depending on unwinding of the transactions and fluctuations in market prices.
Some of the other banks that were affected by this default are Deutsche Bank (DB - Free Report) and UBS Group (UBS - Free Report) . Deutsche Bank's exposure to the fund was very limited in comparison to others. Per a Bloomberg article, the bank did not incur any losses and is in the process of managing its position.
Also, Goldman Sachs expects any loss it may face from Archegos to be immaterial, as its loans to Archegos were fully collateralized. Per the article, Goldman is among the first banks to reduce its exposure and has exited most of its Archegos-related positions.
Shares of Credit Suisse and Nomura have gained 14.3% and 24%, respectively, over the past six months compared with 49.1% growth of the industry.
Price Performance
Both the stocks are currently carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>